What is Desonide 0.05% Cream/Gel/Lotion
Desonide 0.05% comes in three different formulations – cream, gel, and lotion. All the products made by reputable manufacturers Glenmark, Galderma, and Curatio. Desonide is a mild anti-inflammatory solution, usually prescribed for atopic dermatitis (eczema), seborrheic dermatitis, psoriasis, and contact dermatitis in both adults and children. It works by activating natural substances in the skin to reduce swelling, redness, and itching. Desonide 0.05% cream is used to treat a variety of skin conditions (e.g., eczema, dermatitis, allergies, rash). Desonide reduces the swelling, itching, and redness that can occur in these types of conditions.
How to use Desonide 0.05% Cream/Gel/Lotion
Desonide 0.05% cream should be applied on the affected areas as a thin layer two times daily depending on the severity of the condition. It comes as a lotion, gel, cream, and ointment to apply topically. Wash your hands. Before applying the Desonide 0.05% topically, clean, and dry the affected area. Apply a thin film of the Desonide 0.05% cream to the affected area and gently rub in, usually 2-3 times daily, or as directed by your dermatologist. Do not bandage, wrap, or cover the area unless you are instructed to do so by your dermatologist.
When not to use Desonide 0.05% Cream/Gel/Lotion
This medicine is not recommended for use in patients with a known allergy to desonide or any other inactive ingredients present along with it. It is not recommended for use in pregnant or/and breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before using this medicine.
Using Desonide Cream for Eczema
Curatio Healthcare is a specialty dermatology company. The idea behind setting up of Curatio was to provide solutions to address the therapy gaps in the area of general and cosmetic dermatology and speciality dermatology. We use extensive market research to identify the needs of the dermatology fraternity and come up with innovative ideas. These ideas are converted to efficacious products, thanks to the world-class R&D expertise that Curatio and its research partners possess. Established in 2005, Curatio in Latin means “healing”. Curatio has constantly been striving to offer effective solutions to the day-to-day challenges that dermatologists and cosmetologists encounter in their practice. Extensive market research and state-of-the-art R&D are the tools we employ to bring out innovative and effective solutions for these challenges. Curatio, is one among the fastest growing dermatology companies in India, Sri Lanka, Philippines, and Nepal. Curatio believes in ethical operations in its functions. We believe in adhering to all applicable laws, regulations and industry standards. Also, our interaction with healthcare professionals follows the highest ethical standards and we believe that we are promoting our products responsibly on proven medical knowledge.
. is a pharmaceutical subsidiary specializing in the research, development and marketing of dermatological treatments. The company became a wholly owned subsidiary of Nestlé in 2014. Galderma provides a range of products used to treat acne, rosacea, psoriasis and other steroid-responsive dermatoses (SRD), onychomycosis (fungal nail infections), pigmentary disorders, skin cancer and skin senescence. Galderma’s products sell in more than 70 countries. Galderma is the medical solutions brand within Nestlé Skin Health. Given the important role our skin plays in our daily lives, we focus on science-based solutions that will enhance the quality of people's lives. The Code of Ethics is an explicit declaration of adherence to the highest ethical standards in our work. It states that it is the responsibility of every employee to “do the right thing, the right way” to ensure the highest standards of integrity. It means that when we create value for our company and its stakeholders, such as the people and communities we serve, we should do so by acting in an ethical and socially responsible way. The Code reflects the values and behavior that have strongly contributed to making us successful over the years. Galderma provides both prescription drugs and aesthetic solutions, treating compromised skin, enhancing healthy skin, and providing solutions for aging skin. For over 35 years, Galderma has partnered with healthcare professionals and academia across the globe to find innovative solutions to skin issues and deliver safe and effective treatments to meet the skin health needs of people throughout their lifetimes. Galderma provides prescription drugs and aesthetic solutions, going beyond treating skin problems to enhance healthy skin, treat compromised skin and rejuvenate aging skin. Galderma also offers over-the-counter products, providing consumers with the solutions they need to maintain healthy skin throughout their lives. Today, dermatology is receiving a growing amount of recognition and attention. As we are living longer, caring for our skin as we age is also becoming increasingly important. Galderma is spearheading this change in the world’s outlook on skin health. As a focused dermatology company right from the start, Galderma is committed to the healthcare community, providing education and training programs as well as ongoing support to healthcare professionals throughout their career, to enable them to remain at the forefront of their field. Today, Galderma's product portfolio is available in more than 100 countries, offering treatment for a range of dermatological conditions. In the United States, our portfolio includes aesthetic solutions as well as treatments for acne, rosacea, steroid-responsive dermatoses and melasma, and over-the-counter solutions for consumers.
Glenmark Pharmaceuticals Ltd. (GPL) is a research-driven, global, integrated pharmaceutical company headquartered at Mumbai, India. It is ranked among the top 100 Pharma & Biotech companies of the world in terms of revenues. (SCRIP 100 Rankings published in the year 2012). Glenmark is a leading player in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity). Glenmark has several molecules in various stages of clinical development and is primarily focused in the areas of Inflammation [asthma/COPD, rheumatoid arthritis, etc.] and Pain [neuropathic pain and inflammatory pain]. The company has a significant presence in branded generics markets across emerging economies including India. GPL along with its subsidiary has 14 manufacturing facilities in four countries and has six R&D centers spread across India, UK, and Switzerland. It's subsidiary, Glenmark Generics Limited services the requirements of the US and Western Europe generics markets. The API business sells its products in over 80 countries, including the US, various countries in the EU, South America and India. Glenmark
was founded with a vision to emerge as a leading integrated research-based, a global pharmaceutical company. Over the decades, we have established ourselves as a leading player in the discovery of new molecules both NCEs (New Chemical Entity) and NBEs (New Biological Entity). We have several molecules in various stages of pre-clinical and clinical development and are primarily focused in the areas of Oncology, Respiratory and Dermatology. Our branded generics business has a significant presence in markets across emerging economies including India. The generics business services the requirements of developed markets like US and Western Europe. Our API business sells products in over 80 countries including the US, various countries in the EU, South America and India. With 17 manufacturing facilities and 5 R&D centers dedicated to the goal of enriching lives across the globe we believe that the real force behind our continued successes are dedicated employees from across 50 nationalities, committed to creating 'A new way for a new world'.
Desonide (0.05% w/w)
In a gel/cream/lotion base